Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?

Autor: Alvarez-Moreno C; National Clinical Coordinator COVID-19- WHO Studies, Colombia. Clinica Colsanitas and Facultad de Medicina, Universidad Nacional de Colombia, Colombia. Electronic address: caalvarezmo@unal.edu.co., Valderrama-Beltran SL; Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Internal Medicine Department, Colombia; Ph.D. Program in Clinical Epidemiology, Department of Clinical Epidemiology and Biostatistics. Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia., Silva R; World Health Organization. Geneva, Switzerland., De La Hoz Siegler IH; Clinica Colsanitas, Bogotá, Colombia., Varón Vega FA; Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia., Martínez-Vernaza S; Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Internal Medicine Department, Colombia., Blanco TO; Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Internal Medicine Department, Colombia., Padilla M; World Health Organization, PanAmerican Health Organization, Bogotá, Colombia., Mesa-Rubio ML; Universidad de Los Andes, Bogotá, Colombia., Castañeda Pascagaza LC; Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia., Rojas JA; Clínica Universitaria Colombia. Fundación Universitaria Sanitas. Bogotá, Colombia., Bravo Ojeda JS; Clínica Infantil Santa María del Lago, Bogotá, Colombia., Villa J; Clínica el Carmen, Barranquilla, Colombia., Chacón Sarmiento JA; Clínica Reina Sofia, Bogotá, Colombia., Yomayusa N; Clínica Reina Sofia, Bogotá, Colombia., Patiño S; Clínica Sebastián de Belalcázar, Cali, Colombia., Gómez-Nieto K; Clínica Sebastián de Belalcázar, Cali, Colombia., Martínez Pinzón VL; Clínica Iberoamérica, Barranquilla, Colombia., Ramírez Cogollo AM; Hospital Militar Central Colombia, Bogotá, Colombia., Toloza C; Clínica Universitaria Colombia. Fundación Universitaria Sanitas. Bogotá, Colombia., Diaz-Puentes M; Hospital Universitario San Ignacio, Research Office. Pontificia Universidad Javeriana. Bogotá, Colombia., Cañas-Arboleda A; Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Internal Medicine Department, Colombia., Manrique-Andrade M; Hospital Universitario San Ignacio, Research Office. Pontificia Universidad Javeriana. Bogotá, Colombia., Ayub RT; Clínica Iberoamérica, Barranquilla, Colombia., López Mora MJ; Hospital Militar Central Colombia, Bogotá, Colombia., Pachón Espinosa MJ; Hospital Militar Central Colombia, Bogotá, Colombia., Cortés JA; Hospital Universitario Nacional de Colombia, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia., Sánchez LC; Hospital Universitario Nacional de Colombia, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia., Chacón Acevedo KR; Instituto Global de Excelencia Clínica, Grupo de Investigación Traslacional. Keralty, Bogotá, Colombia., Rengifo P; Clinica Colsanitas, Bogotá, Colombia., Tambini G; World Health Organization, PanAmerican Health Organization, Department of Evidence and Intelligence for Action in Health (EIH), Washington, USA; World Health Organization, PanAmerican Health Organization, Bogotá, Colombia., Bertagnolio S; World Health Organization. Geneva, Switzerland., Diaz J; World Health Organization. Geneva, Switzerland., Thwin SS; World Health Organization. Geneva, Switzerland., Reveiz L; World Health Organization, PanAmerican Health Organization, Department of Evidence and Intelligence for Action in Health (EIH), Washington, USA.

Publikováno v: Travel medicine and infectious disease [Travel Med Infect Dis] 2023 May-Jun; Vol. 53, pp. 102579. Date of Electronic Publication: 2023 May 09.

A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies.

Autor: Ibargoyen-Roteta N; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain., Galnares-Cordero L; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain., Benguria-Arrate G; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain., Chacón-Acevedo KR; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Gutiérrez-Sepulveda MP; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Low-Padilla E; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., De La Hoz-Siegler IH; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Guevara-Pérez CI; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Del Pozo-Pérez Á; Biokeralty Research Institute AIE, Miñano, Spain., Suárez M; Biokeralty Research Institute AIE, Miñano, Spain., Dauben HP; dkHealth Partners, Cologne, Germany., Otte M; International HealthTechScan (i-HTS), Cologne, Germany., Gutiérrez-Ibarluzea I; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain.; Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain.

Publikováno v: Frontiers in public health [Front Public Health] 2022 Oct 06; Vol. 10, pp. 942230. Date of Electronic Publication: 2022 Oct 06 (Print Publication: 2022).